Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Sales | 6,452,400 | 6,167,300 | 5,725,700 | 5,191,600 | 4,175,600 |
| Cost of Goods | 1,959,000 | 1,897,000 | 1,717,700 | 1,586,300 | 1,255,800 |
| Gross Profit | 4,493,400 | 4,270,300 | 4,071,500 | 3,668,300 | 2,919,800 |
| Operating Expenses | 2,668,100 | 2,549,100 | 2,240,400 | 2,066,200 | 1,755,800 |
| Operating Income | 1,825,300 | 1,721,200 | 1,768,300 | 1,539,400 | 1,164,800 |
| Other Income | -1,123,400 | -538,900 | 110,900 | 59,600 | 165,100 |
| Pre-tax Income | 701,900 | 1,182,300 | 1,879,200 | 1,599,000 | 1,329,900 |
| Income Tax | 210,800 | 354,700 | 564,500 | 471,700 | 390,400 |
| Net Income Continuous | 1,347,100 | 1,223,595 | 1,314,700 | 1,127,300 | 939,500 |
| Net Income Discontinuous | -10,900 | -118,900 | 0 | 0 | 0 |
| Net Income | $480,200 | $708,700 | $1,314,700 | $1,127,300 | $939,500 |
| EPS Basic Total Ops | 0.41 | 0.61 | 1.12 | 1.04 | 0.85 |
| EPS Basic Continuous Ops | 1.15 | 1.05 | 1.12 | 1.06 | 0.84 |
| EPS Basic Discontinuous Ops | -0.01 | -0.10 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.41 | 0.61 | 1.12 | 1.02 | 0.84 |
| EPS Diluted Continuous Ops | 1.15 | 1.05 | 1.12 | 1.02 | 0.84 |
| EPS Diluted Discontinuous Ops | -0.01 | -0.10 | N/A | N/A | N/A |
| EBITDA(a) | $2,223,600 | $2,089,300 | $2,067,800 | $1,786,900 | $1,394,100 |